Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation RM Stone, SJ Mandrekar, BL Sanford, K Laumann, S Geyer, ... New England Journal of Medicine 377 (5), 454-464, 2017 | 2140 | 2017 |
Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis … C Thiede, C Steudel, B Mohr, M Schaich, U Schäkel, U Platzbecker, ... Blood 99 (12), 4326-4335, 2002 | 2128 | 2002 |
Retinoic acid and arsenic trioxide for acute promyelocytic leukemia F Lo-Coco, G Avvisati, M Vignetti, C Thiede, SM Orlando, S Iacobelli, ... N Engl J Med 369, 111-121, 2013 | 1580 | 2013 |
Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection E Bayerdörffer, B Rudolph, A Neubauer, C Thiede, N Lehn, S Eidt, ... The Lancet 345 (8965), 1591-1594, 1995 | 1293 | 1995 |
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party GJ Schuurhuis, M Heuser, S Freeman, MC Béné, F Buccisano, J Cloos, ... Blood, The Journal of the American Society of Hematology 131 (12), 1275-1291, 2018 | 1060 | 2018 |
Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML) C Thiede, S Koch, E Creutzig, C Steudel, T Illmer, M Schaich, G Ehninger, ... Blood 107 (10), 4011-4020, 2006 | 971 | 2006 |
T (11; 18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication H Liu, H Ye, A Ruskone–Fourmestraux, D De Jong, S Pileri, C Thiede, ... Gastroenterology 122 (5), 1286-1294, 2002 | 548 | 2002 |
Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2 … C Röllig, H Serve, A Hüttmann, R Noppeney, C Müller-Tidow, U Krug, ... The lancet oncology 16 (16), 1691-1699, 2015 | 446 | 2015 |
Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial U Platzbecker, M Wermke, J Radke, U Oelschlaegel, F Seltmann, A Kiani, ... Leukemia 26 (3), 381-389, 2012 | 442 | 2012 |
Cure of Helicobacter pylori Infection and Duration of Remission of Low-Grade Gastric Mucosa-Associated Lymphoid Tissue Lymphoma A Neubauer, C Thiede, B Alpen, M Ritter, B Neubauer, G Ehninger, ... Journal of the National Cancer Institute 89 (18), 1350-1355, 1997 | 418 | 1997 |
Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3–Internal Tandem Duplication Mutation … A Burchert, G Bug, LV Fritz, J Finke, M Stelljes, C Röllig, E Wollmer, ... Journal of Clinical Oncology 38 (26), 2993-3002, 2020 | 400 | 2020 |
Improved outcomes with retinoic acid and arsenic trioxide compared with retinoic acid and chemotherapy in non-high-risk acute promyelocytic leukemia: final results of the … U Platzbecker, G Avvisati, L Cicconi, C Thiede, F Paoloni, M Vignetti, ... American Society of Clinical Oncology 35 (6), 605-612, 2017 | 394 | 2017 |
Long-Term Follow-Up of Gastric MALT Lymphoma After Helicobacter Pylori Eradication T Wündisch, C Thiede, A Morgner, A Dempfle, A Günther, H Liu, H Ye, ... Journal of clinical Oncology 23 (31), 8018-8024, 2005 | 383 | 2005 |
Sorafenib in combination with intensive chemotherapy in elderly patients with acute myeloid leukemia: results from a randomized, placebo-controlled trial H Serve, U Krug, R Wagner, MC Sauerland, A Heinecke, U Brunnberg, ... Journal of Clinical Oncology 31 (25), 3110-3118, 2013 | 382 | 2013 |
Helicobacter heilmannii–associated primary gastric low-grade MALT lymphoma: complete remission after curing the infection A Morgner, N Lehn, LP Andersen, C Thiede, M Bennedsen, K Trebesius, ... Gastroenterology 118 (5), 821-828, 2000 | 380 | 2000 |
Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging. MALT Lymphoma Study Group M Sackmann, A Morgner, B Rudolph, A Neubauer, C Thiede, H Schulz, ... Gastroenterology 113 (4), 1087-1090, 1997 | 378 | 1997 |
Helicobacter and gastric MALT lymphoma M Stolte, E Bayerdörffer, A Morgner, B Alpen, T Wündisch, C Thiede, ... Gut 50 (suppl 3), iii19-iii24, 2002 | 373 | 2002 |
Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes U Krug, C Röllig, A Koschmieder, A Heinecke, MC Sauerland, M Schaich, ... The Lancet 376 (9757), 2000-2008, 2010 | 348 | 2010 |
MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients T Illmer, US Schuler, C Thiede, UI Schwarz, RB Kim, S Gotthard, D Freund, ... Cancer research 62 (17), 4955-4962, 2002 | 346 | 2002 |
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party M Heuser, SD Freeman, GJ Ossenkoppele, F Buccisano, CS Hourigan, ... Blood, The Journal of the American Society of Hematology 138 (26), 2753-2767, 2021 | 345 | 2021 |